Evidence map›Paper›PMID 26349661›Full record

ArticleMucosal immunology2016

IFN-γ induction by neutrophil-derived IL-17A homodimer augments pulmonary antibacterial defense.

S Cai, S Batra, I Langohr, Y Iwakura, S Jeyaseelan

Open access · bronzeAbstract read
In one paragraph

Article in Mucosal immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections.Journal of immunology (Baltimore, Md. : 1950) · 2020
    Review
  16. Review
  17. Article
  18. Article
  19. Integrative Physiology of Pneumonia.Physiological reviews · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

S CaiLaboratory of Lung Biology, Department of Pathobiological Sciences and Center for Experimental Infectious Disease Research, School of Veterinary Medicine, Louisiana State University (LSU), Baton Rouge, Louisiana, USA.
S BatraLaboratory of Lung Biology, Department of Pathobiological Sciences and Center for Experimental Infectious Disease Research, School of Veterinary Medicine, Louisiana State University (LSU), Baton Rouge, Louisiana, USA.
I LangohrLaboratory of Lung Biology, Department of Pathobiological Sciences and Center for Experimental Infectious Disease Research, School of Veterinary Medicine, Louisiana State University (LSU), Baton Rouge, Louisiana, USA.
Y IwakuraCenter for Experimental Medicine and Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama, Japan.
S JeyaseelanLaboratory of Lung Biology, Department of Pathobiological Sciences and Center for Experimental Infectious Disease Research, School of Veterinary Medicine, Louisiana State University (LSU), Baton Rouge, Louisiana, USA.
Louisiana State University · USJapan Science and Technology Agency · JPLouisiana State University Health Sciences Center New Orleans · US

Funding

TNF AND MCP-1 IN RETROVIRUS-INDUCED BRAIN DISEASEP20RR020159 · NCRR · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI PAHAR, BAPI · 2004 to 2011
$16.1M
Protein CoreP30GM110760 · NIGMS · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI KOUSOULAS, KONSTANTIN G · 2014 to 2018
$5.6M
Neutrophil Accumulation in Bacterial PneumoniaR01HL091958 · NHLBI · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI JEYASEELAN, SAMITHAMBY · 2008 to 2017
$3.8M
Neutrophil Function in Bacterial PneumoniaR01AI113720 · NIAID · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI JEYASEELAN, SAMITHAMBY · 2015 to 2019
$1.9M
NOD-Like Receptor Signaling is Critical to Secondhand Smoke-Induced Immunity andR15ES023151 · NIEHS · SOUTHERN UNIV A&M COL BATON ROUGE · PI BATRA, SANJAY · 2013 to 2016
$369k
NCRR NIH HHS P20 RR020159NHLBI NIH HHS R01 HL091958NIAID NIH HHS R01 AI113720NIEHS NIH HHS R15 ES023151NIGMS NIH HHS P30 GM110760
6 · The paper itself

Abstract

The role of interleukin-17A (IL-17A) in host defense against Legionella pneumophila remains elusive. To address this issue, we used Il17a(-/-), Il17f(-/-), and Il17a/Il17f(-/-) mice on a C57Bl/6 (non-permissive) background and IL-17 neutralizing Abs in mice on an A/J (permissive) background. Higher bacterial (L. pneumophila) counts in the lung and blood along with reduced neutrophil recruitment were detected in Il17a(-/-), but not Il17f(-/-), mice. We found that neutrophils produce IL-17A homodimer (IL-17A) during L. pneumophila infection, and hematopoietic cell-derived IL-17A is known to be important for bacterial clearance. Thus, intratracheal administration of wild-type neutrophils or recombinant IL-17A restored bacterial clearance and neutrophil recruitment in Il17a(-/-) mice. Furthermore, neutrophil-depleted Rag2(-/-) and Rag2/Il-2rγ(-/-) mice exhibited increased bacterial burden, reduced neutrophil influx and IL-17A production in the lung. Recombinant IFN-γ administration in Il17a(-/-) mice augmented bacterial elimination, whereas IL-17A administration in Ifnγ(-/-) mice did not augment bacterial clearance. IFN-γ is produced by T cells, but not neutrophils or macrophages, suggesting that neutrophil-derived IL-17A induces IFN-γ in a paracrine fashion. Human pneumonic lungs and human neutrophils challenged with L. pneumophila exhibited increased numbers of IL-17A producing cells. These findings display a novel function of neutrophil-derived IL-17A in antibacterial defense via the induction of IFN-γ in a paracrine manner.

Indexed as

AnimalsAntibodies, NeutralizingBacterial LoadCells, CulturedDimerizationFemaleHumansInterferon-gammaInterleukin-17Legionella pneumophilaLegionnaires' DiseaseLungMiceMice, Inbred C57BLMice, KnockoutNeutrophil InfiltrationAntibodies, NeutralizingInterferon-gammaInterleukin-17

Identifiers

PMID26349661
PMCPMC4785101
OpenAlexW1428310817

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.